BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29949154)

  • 1. Up-regulation of miR-765 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
    Jiang B; Xu G; Lv HQ; Huang M; Li Z
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3789-3794. PubMed ID: 29949154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F.
    Yang H; Wei YN; Zhou J; Hao TT; Liu XL
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3200-3206. PubMed ID: 28770965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of miR-335 predicts a favorable prognosis in esophageal squamous cell carcinoma.
    Zhang BJ; Gong HY; Zheng F; Liu DJ; Liu HX
    Int J Clin Exp Pathol; 2014; 7(9):6213-8. PubMed ID: 25337272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma.
    Sun N; Ye L; Chang T; Li X; Li X
    Int J Clin Exp Pathol; 2014; 7(10):6871-9. PubMed ID: 25400770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma.
    Qi B; Lu JG; Yao WJ; Chang TM; Qin XG; Ji YH; Wang TY; Liu SG; Li HC; Liu YZ; Zhao BS
    World J Gastroenterol; 2015 Jun; 21(22):6884-91. PubMed ID: 26078564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
    Zhang Y; Liu YP; Du K; Wang H; Wang XL
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
    Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
    Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of microRNA-34a in esophageal squamous cell carcinoma.
    Lin X; Xu XY; Chen QS; Huang C
    Genet Mol Res; 2015 Dec; 14(4):17684-91. PubMed ID: 26782413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and clinical significance of C14orf166 in esophageal squamous cell carcinoma.
    Zhou YW; Li R; Duan CJ; Gao Y; Cheng YD; He ZW; Zeng JX; Zhang CF
    Mol Med Rep; 2017 Feb; 15(2):605-612. PubMed ID: 28000881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression level and clinical significance of LncRNA HOXA11-AS in esophageal squamous cell carcinoma patients].
    Sun XY; Wang XF; Cui YB; Cao XG; Zhao RH; Wei HY; Cao W; Wu W
    Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):186-190. PubMed ID: 29575836
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic value of microRNA-100 in esophageal squamous cell carcinoma.
    Zhou S; Yang B; Zhao Y; Xu S; Zhang H; Li Z
    J Surg Res; 2014 Dec; 192(2):515-20. PubMed ID: 25218280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical potential of miR-3651 as a novel prognostic biomarker for esophageal squamous cell cancer.
    Wang C; Guan S; Chen X; Liu B; Liu F; Han L; Un Nesa E; Song Q; Bao C; Wang X; Cheng Y
    Biochem Biophys Res Commun; 2015 Sep; 465(1):30-4. PubMed ID: 26210449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
    Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
    Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
    Wei R; Shang Z; Leng J; Cui L
    J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA SNHG16 predicts poor prognosis in ESCC and promotes cell proliferation and invasion by regulating Wnt/β-catenin signaling pathway.
    Han GH; Lu KJ; Wang P; Ye J; Ye YY; Huang JX
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3795-3803. PubMed ID: 29949155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2.
    Zhou YW; Zhang H; Duan CJ; Gao Y; Cheng YD; He D; Li R; Zhang CF
    Oncotarget; 2016 May; 7(21):30730-47. PubMed ID: 27120794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-145 expression level in tissue predicts prognosis of patients with esophageal squamous cell carcinoma.
    Jin W; Luo W; Fang W; Wang Y; Wang L; Shen Q; Liu W; Zhang H
    Pathol Res Pract; 2019 Jun; 215(6):152401. PubMed ID: 31014553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinoma.
    Chen YF; Ma G; Cao X; Huang ZL; Zeng MS; Wen ZS
    Med Oncol; 2014 Dec; 31(12):317. PubMed ID: 25377660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of GRB2 is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Li LY; Li EM; Wu ZY; Cao HH; Shen JH; Xu XE; Chen B; Wu JY; Xu LY
    Int J Clin Exp Pathol; 2014; 7(6):3132-40. PubMed ID: 25031732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.